Alzheimer's Deaths Prompt FDA to Tighten Lecanemab Rules

(MedPage Today) — The FDA will require earlier, additional MRI monitoring for Alzheimer’s disease patients taking lecanemab (Leqembi), an amyloid-directed treatment given by IV infusion, the agency said Thursday.
The agency called for the drug…

Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/117218

Author :

Publish date : 2025-08-29 14:05:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Alzheimer’s Deaths Prompt FDA to Tighten Lecanemab Rules

Falls Lead to Brain Bleeds in About 7% of Older Adults

Medical Groups Sue RFK Jr. Over AHRQ Grant Shutdown

Related Posts

State Laws on Unilateral Decisions for Life Support Are All Over the Map

Getting a COVID Shot Just Became Much More Difficult. Here’s Why.

‘Weekend Warriors’ See Lower Gout Risk, Similar to Gym Rats

‘Parkinson’s Largely Is a Preventable Disease’

The Evisceration of CDC Is a Disaster for All of Us

Bespoke brain implant gives long-term relief from chronic pain

State Laws on Unilateral Decisions for Life Support Are All Over the Map

Getting a COVID Shot Just Became Much More Difficult. Here’s Why.

‘Weekend Warriors’ See Lower Gout Risk, Similar to Gym Rats

‘Parkinson’s Largely Is a Preventable Disease’

The Evisceration of CDC Is a Disaster for All of Us

Bespoke brain implant gives long-term relief from chronic pain

Mind-Body Exercise for Cancer Pain; Sunscreens and Politics; Bring on the Red Meat

Raising Potassium Cuts Arrhythmias in ICD Patients

Categories

Archives